These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3054757)

  • 1. [Effect of fosfomycin on cellular immune reactions as affected by cyclophosphamide or corticosteroids].
    Gillissen G; Breuer-Werle M; Ostendorp H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):731-4. PubMed ID: 3054757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Escherichia coli 06 infection in mice. II. Protective factors of immunity after immunosuppression.
    Ahlstedt S
    Scand J Infect Dis Suppl; 1980; Suppl 24():216-9. PubMed ID: 7010558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cefaclor on immune response parameters.
    Gillissen G
    Arzneimittelforschung; 1984; 34(11):1535-40. PubMed ID: 6335399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased resistance towards two systemic experimental infections by tetrachlorodecaoxygen anion complex. Possible implications of cellular and humoral immunity.
    Gillissen G; Kühne FW; Breuer-Werle M; Melzer B; Ostendorp H
    Arzneimittelforschung; 1986 Dec; 36(12):1778-82. PubMed ID: 3566839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Inverse" effects of cortisone in experimental infection of mice.
    Gillissen G
    Adv Exp Med Biol; 1992; 319():137-43. PubMed ID: 1414589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide.
    Mokyr MB; Dray S
    Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose cyclophosphamide inhibition of transplantable fibrosarcoma growth by augmentation of the host immune response.
    Ray PK; Raychaudhuri S
    J Natl Cancer Inst; 1981 Dec; 67(6):1341-5. PubMed ID: 6947115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of sheep erythrocyte (SRBC)-induced pleurisy in non-sensitized mice by cyclophosphamide: demonstration of natural cell-mediated immune reactivity to SRBC.
    Yamamoto S; Higuchi Y; Teshima H
    Immunology; 1982 Sep; 47(1):31-40. PubMed ID: 7118162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant mouse model of E. coli diarrhoea: clinical protection induced by vaccination of the mothers.
    Duchet-Suchaux M
    Ann Rech Vet; 1983; 14(3):319-31. PubMed ID: 6362544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Schiffman G
    Cancer Res; 1981 Mar; 41(3):801-7. PubMed ID: 7459867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F; Marić M; Morović-Vergles J
    In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin.
    Artym J; Zimecki M; Kruzel ML
    Int Immunopharmacol; 2004 Sep; 4(9):1149-57. PubMed ID: 15251111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 16. [Additive effect of an immunomodulator on the therapeutic effect of antibiotics].
    Gillissen G; Breuer-Werle M
    Pathol Biol (Paris); 1983 Jun; 31(6):548-50. PubMed ID: 6348668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fractional cyclophosphamide dosage on sheep red blood cell-delayed-type hypersensitivity response in mice.
    Rondinone SN; Giovanniello OA; Barrios HA; Nota NR
    J Immunol; 1983 Apr; 130(4):1600-3. PubMed ID: 6220061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cyclophosphamide on immunological control mechanisms.
    Turk JL; Parker D; Cameron AE
    Int J Tissue React; 1984; 6(3):205-11. PubMed ID: 6480267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed-type hypersensitivity to sheep red blood cells in selected lines of mice with high or low antibody responses.
    Lagrange PH; Michel JC; Hurtrel B; Thickstun PM
    Ann Immunol (Paris); 1980; 131C(3):257-77. PubMed ID: 7406440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.